Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.

Research output: Contribution to journalArticle

Abstract

B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.

Original languageEnglish (US)
Pages (from-to)23-36
Number of pages14
JournalClinical Journal of Oncology Nursing
Volume11
Issue number1 Suppl
StatePublished - Feb 2007

Fingerprint

Idiopathic Thrombocytopenic Purpura
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Therapeutics
Natural History
Observation
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{3d75c0859d9944a49015cc9541a32c4b,
title = "Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.",
abstract = "B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.",
author = "Amy Goodrich",
year = "2007",
month = "2",
language = "English (US)",
volume = "11",
pages = "23--36",
journal = "Clinical Journal of Oncology Nursing",
issn = "1092-1095",
publisher = "Oncology Nursing Society",
number = "1 Suppl",

}

TY - JOUR

T1 - Emerging therapeutic options for B-cell disorders

T2 - idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.

AU - Goodrich, Amy

PY - 2007/2

Y1 - 2007/2

N2 - B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.

AB - B-cell disorders include a large group of malignant and nonmalignant diseases with tremendous variation in incidence, natural history, treatment, and prognosis. This article will focus on adult idiopathic thrombocytopenic purpura (ITP) and chronic lymphocytic leukemia (CLL). Clinicians must individualize treatment for ITP and CLL to each patient. Observation without intervention is appropriate for some patients, whereas immediate treatment is indicated for others. Deciding when to treat and which agents to use can be difficult, but new therapeutic options are emerging for both conditions.

UR - http://www.scopus.com/inward/record.url?scp=34248573614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248573614&partnerID=8YFLogxK

M3 - Article

C2 - 17474175

AN - SCOPUS:34248573614

VL - 11

SP - 23

EP - 36

JO - Clinical Journal of Oncology Nursing

JF - Clinical Journal of Oncology Nursing

SN - 1092-1095

IS - 1 Suppl

ER -